NCT00396253View on ClinicalTrials.gov

A Study of Tenecteplase for Restoration of Function in Dysfunctional Hemodialysis (HD) Catheters

PHASE3CompletedINTERVENTIONAL
Enrollment

223

Participants

Timeline

Start Date

November 30, 2006

Primary Completion Date

October 31, 2008

Study Completion Date

October 31, 2008

Conditions
Dysfunctional Hemodialysis Catheters
Interventions
DRUG

Tenecteplase

2 mL (2 mg) of reconstituted lyophilized tenecteplase instilled into each lumen of the HD catheter.

Sponsors

Lead Sponsor

Genentech, Inc.
All Listed Sponsors
lead

Genentech, Inc.

INDUSTRY